Rl. Kramer et al., EFFECT OF ADJUSTMENT OF MATERNAL SERUM ALPHA-FETOPROTEIN LEVELS IN INSULIN-DEPENDENT DIABETES-MELLITUS, American journal of medical genetics, 75(2), 1998, pp. 176-178
Our objective was to determine the effect of the 20% upward adjustment
of maternal serum alphafetoprotein (MSAFP) in patients with insulin-d
ependent diabetes mellitus (IDDM) on the number of patients that would
be classified at increased risk for pregnancy complicated by either D
own syndrome (DS) or neural tube defect (NTD), We retrospectively eval
uated a database containing 63,110 patients who underwent multiple ser
um marker screening between 14 and 22 weeks gestation; 620 patients wi
th IDDM had measurements of MSAFP of which 479 also had measurements o
f beta-HCG, allowing calculation of DS risk, Increased NTD risk was de
fined as MSAFP >2.5 MOM while increased DS risk was defined as a calcu
lated risk greater than or equal to 1/270. One IDDM patient delivered
an infant with a NTD; it was not detected on serum screening. No infan
ts were born with DS, Of the 620 patients with MSAFP determinations, 9
had values >2.5 MOM before adjustment, After upward adjustment, 7 add
itional patients were identified. Sixteen patients were identified at
increased risk for DS before and after adjustment, Our data suggest th
at the 20% upward adjustment of MSAFP increases by 78%, the number of
patients who would require further evaluation for NTD's, Although we w
ere able to identify 620 women with IDDM who underwent serum screening
for NTD, the low prevalence of NTD's did not allow us to demonstrate
an increased detection rate, The effect of upward adjustment of MSAFP
on the number of patients categorized at increased DS risk appears to
be minimal. (C) 1998 Wiley-Liss, Inc.